Medicare to limit coverage of contentious Alzheimer’s drug – Politico

With help from Megan R. Wilson and Katherine Ellen Foley Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Care’s morning newsletter, which is delivered to our subscribers each morning at 6 a.m. The POLITICO Pro platform combines the news you need with tools you can use to take action on the day’s biggest stories. Act on the news with POLITICO Pro . Quick Fix — Medicare proposes covering a controversial Alzheimer’s drug only if patients are in a clinical trial.

Read the source article at Politics, Policy, Political News
2022-01-12 01:00:04

You might also be interested in:

Democrats hit new crossroad in drug pricing talks 12/03/2021
Biogen’s Breakthrough Alzheimer’s Drug May Not Reach Patients… 06/02/2021
Insurers Refuse to Pay for New Alzheimer’s Drug Without… 11/29/2021
Politico Live: 2022 Health Care Summit 03/29/2022
Why So Few Value Assessments On Health Services And… 02/09/2022
Biogen Partners with Cigna and CVS Health to Promote Access to… 06/16/2021
Value & Outcomes Spotlight: Using RWE/RWD to Drive Health Policy 04/05/2022